CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
Phase 2 Unknown
173 enrolled
RECOGNISE
Phase 2 Unknown
25 enrolled
CZCNRHNSCC
Phase 2 Unknown
52 enrolled
MITO CERV 2
Phase 2 Unknown
108 enrolled
AIO-KRK-0116
Phase 2 Unknown
109 enrolled
V-CHANCE
Phase 2 Unknown
39 enrolled
COSTIC
Phase 2 Unknown
33 enrolled
Toripalimab in Combined With Cetuximab,Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
Phase 2 Unknown
33 enrolled
The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment
Phase 2 Unknown
50 enrolled
CETIDYL
Phase 2 Unknown
72 enrolled
SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer
Phase 2 Unknown
90 enrolled
Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer
Phase 2 Unknown
23 enrolled
SLURP
Phase 2 Unknown
25 enrolled
A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer
Phase 2 Unknown
84 enrolled
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Phase 2 Unknown
35 enrolled
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
Phase 2 Unknown
100 enrolled
A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer
Phase 2 Unknown
50 enrolled
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
Phase 2 Unknown
75 enrolled
Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)
Phase 2 Unknown
30 enrolled
FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
Phase 2 Unknown
160 enrolled
c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI
Phase 2 Unknown
120 enrolled
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Phase 2 Unknown
100 enrolled
AVETUXIRI
Phase 2 Unknown
59 enrolled
Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
100 enrolled
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
Phase 2 Unknown
39 enrolled
CELIM2
Phase 2 Unknown
91 enrolled
CARACAS
Phase 2 Unknown
54 enrolled
LERFOX-C
Phase 2 Unknown
51 enrolled
I-Tackle
Phase 2 Unknown
43 enrolled
Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer
Phase 2 Unknown
130 enrolled
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Phase 2 Unknown
152 enrolled
CRICKET
Phase 2 Unknown
27 enrolled
Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
150 enrolled
A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer
Phase 2 Unknown
50 enrolled
Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy
Phase 2 Unknown
60 enrolled
Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer
Phase 2 Unknown
54 enrolled
DEEPER
Phase 2 Unknown
360 enrolled
A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab
Phase 2 Unknown
74 enrolled
OPTILIV
Phase 2 Unknown
60 enrolled
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
51 enrolled
CETMET
Phase 2 Unknown
120 enrolled
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
Phase 2 Unknown
46 enrolled
XERT
Phase 2 Unknown
43 enrolled
Treatment Selection According to Skin Reaction to Cetuximab
Phase 2 Unknown
120 enrolled
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2 Unknown
100 enrolled
CLIME
Phase 2 Unknown
90 enrolled
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
Phase 2 Unknown
30 enrolled
Dux
Phase 2 Unknown
50 enrolled
EXPERT-C
Phase 2 Unknown
164 enrolled
Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients
Phase 2 Unknown
60 enrolled